Tech Company Financing Transactions

PhaseBio Pharmaceuticals Funding Round

On 9/6/2018, PhaseBio Pharmaceuticals announced $34 million in Series D financing from AstraZeneca, Cormorant Asset Management and Fletcher Spaght Ventures.

Transaction Overview

Announced On
9/6/2018
Transaction Type
Venture Equity
Amount
$34,000,000
Round
Series D
Proceeds Purpose
PhaseBio plans to use the proceeds from the Series D financing to advance the clinical development of its lead product candidate PB2452.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1 Great Valley Pkwy. 30
Malvern, PA 19355
USA
Email Address
Not Recorded
Overview
PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), located in Malvern, PA, is a development stage, privately held protein engineering company focused on developing the next generation of biopharmaceuticals.
Profile
PhaseBio Pharmaceuticals LinkedIn Company Profile
Social Media
PhaseBio Pharmaceuticals Company Twitter Account
Company News
PhaseBio Pharmaceuticals News
Facebook
PhaseBio Pharmaceuticals on Facebook
YouTube
PhaseBio Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jonathan Mow
  Jonathan Mow LinkedIn Profile  Jonathan Mow Twitter Account  Jonathan Mow News  Jonathan Mow on Facebook
Chief Financial Officer
John Sharp
  John Sharp LinkedIn Profile  John Sharp Twitter Account  John Sharp News  John Sharp on Facebook
Chief Medical Officer
John Lee
  John Lee LinkedIn Profile  John Lee Twitter Account  John Lee News  John Lee on Facebook
VP - Bus. Development
Susan Arnold
  Susan Arnold LinkedIn Profile  Susan Arnold Twitter Account  Susan Arnold News  Susan Arnold on Facebook
VP - Bus. Development
Michael York
  Michael York LinkedIn Profile  Michael York Twitter Account  Michael York News  Michael York on Facebook
VP - R & D
James Ballance
  James Ballance LinkedIn Profile  James Ballance Twitter Account  James Ballance News  James Ballance on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/6/2018: Arkose Labs venture capital transaction
Next: 9/6/2018: Cricket Health venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to document tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary